197 related articles for article (PubMed ID: 21819638)
1. Increased metacyclogenesis of antimony-resistant Leishmania donovani clinical lines.
Ouakad M; Vanaerschot M; Rijal S; Sundar S; Speybroeck N; Kestens L; Boel L; De Doncker S; Maes I; Decuypere S; Dujardin JC
Parasitology; 2011 Sep; 138(11):1392-9. PubMed ID: 21819638
[TBL] [Abstract][Full Text] [Related]
2. Proteophosphoglycan is differentially expressed in sodium stibogluconate-sensitive and resistant Indian clinical isolates of Leishmania donovani.
Samant M; Sahasrabuddhe AA; Singh N; Gupta SK; Sundar S; Dube A
Parasitology; 2007 Aug; 134(Pt 9):1175-84. PubMed ID: 17362540
[TBL] [Abstract][Full Text] [Related]
3. Assessing aquaglyceroporin gene status and expression profile in antimony-susceptible and -resistant clinical isolates of Leishmania donovani from India.
Mandal S; Maharjan M; Singh S; Chatterjee M; Madhubala R
J Antimicrob Chemother; 2010 Mar; 65(3):496-507. PubMed ID: 20067981
[TBL] [Abstract][Full Text] [Related]
4. Increased parasite surface antigen-2 expression in clinical isolates of Leishmania donovani augments antimony resistance.
Bhandari V; Kumar D; Verma S; Srividya G; Negi NS; Singh R; Salotra P
Biochem Biophys Res Commun; 2013 Nov; 440(4):646-51. PubMed ID: 24103752
[TBL] [Abstract][Full Text] [Related]
5. Studies on stibanate resistant Leishmania donovani isolates of Indian origin.
Pal S; Mandal A; Duttagupta S
Indian J Exp Biol; 2001 Mar; 39(3):249-54. PubMed ID: 11495284
[TBL] [Abstract][Full Text] [Related]
6. Characterisation of antimony-resistant Leishmania donovani isolates: biochemical and biophysical studies and interaction with host cells.
Mukhopadhyay R; Mukherjee S; Mukherjee B; Naskar K; Mondal D; Decuypere S; Ostyn B; Prajapati VK; Sundar S; Dujardin JC; Roy S
Int J Parasitol; 2011 Nov; 41(13-14):1311-21. PubMed ID: 21920365
[TBL] [Abstract][Full Text] [Related]
7. Evidence that the high incidence of treatment failures in Indian kala-azar is due to the emergence of antimony-resistant strains of Leishmania donovani.
Lira R; Sundar S; Makharia A; Kenney R; Gam A; Saraiva E; Sacks D
J Infect Dis; 1999 Aug; 180(2):564-7. PubMed ID: 10395884
[TBL] [Abstract][Full Text] [Related]
8. Possibility of membrane modification as a mechanism of antimony resistance in Leishmania donovani.
Kothari H; Kumar P; Sundar S; Singh N
Parasitol Int; 2007 Mar; 56(1):77-80. PubMed ID: 17169604
[TBL] [Abstract][Full Text] [Related]
9. Leishmania donovani: an in vitro study of antimony-resistant amphotericin B-sensitive isolates.
Sharief AH; Gasim Khalil EA; Theander TG; Kharazmi A; Omer SA; Ibrahim ME
Exp Parasitol; 2006 Dec; 114(4):247-52. PubMed ID: 16716301
[TBL] [Abstract][Full Text] [Related]
10. Stage-specific activity of pentavalent antimony against Leishmania donovani axenic amastigotes.
Ephros M; Bitnun A; Shaked P; Waldman E; Zilberstein D
Antimicrob Agents Chemother; 1999 Feb; 43(2):278-82. PubMed ID: 9925518
[TBL] [Abstract][Full Text] [Related]
11. Leishmania donovani: effect of verapamil on in vitro susceptibility of promastigote and amastigote stages of Indian clinical isolates to sodium stibogluconate.
Valiathan R; Dubey ML; Mahajan RC; Malla N
Exp Parasitol; 2006 Oct; 114(2):103-8. PubMed ID: 16616137
[TBL] [Abstract][Full Text] [Related]
12. Metabolic adaptations of Leishmania donovani in relation to differentiation, drug resistance, and drug pressure.
Berg M; Vanaerschot M; Jankevics A; Cuypers B; Maes I; Mukherjee S; Khanal B; Rijal S; Roy S; Opperdoes F; Breitling R; Dujardin JC
Mol Microbiol; 2013 Oct; 90(2):428-42. PubMed ID: 24020363
[TBL] [Abstract][Full Text] [Related]
13. Leishmania donovani: genetic diversity of isolates from Sudan characterized by PCR-based RAPD.
Hamad SH; Khalil EA; Musa AM; Ibrahim ME; Younis BM; Elfaki ME; El-Hassan AM;
Exp Parasitol; 2010 Aug; 125(4):389-93. PubMed ID: 20346944
[TBL] [Abstract][Full Text] [Related]
14. [A case of antimony resistant kala-azar cured with amphotericin B].
Chen SB; Yang CM; Zhang CJ
Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi; 2007 Jun; 25(3):inside front page. PubMed ID: 18038767
[No Abstract] [Full Text] [Related]
15. Lipase Precursor-Like Protein Promotes Miltefosine Tolerance in Leishmania donovani by Enhancing Parasite Infectivity and Eliciting Anti-inflammatory Responses in Host Macrophages.
Deep DK; Singh R; Kulshrestha A; Wajid S; Salotra P
Antimicrob Agents Chemother; 2018 Dec; 62(12):. PubMed ID: 30297367
[TBL] [Abstract][Full Text] [Related]
16. Integrating genomics and proteomics permits identification of immunodominant antigens associated with drug resistance in human visceral leishmaniasis in India.
Singh N; Sundar S
Exp Parasitol; 2017 May; 176():30-45. PubMed ID: 28263760
[TBL] [Abstract][Full Text] [Related]
17. Characterization of the proliferating cell nuclear antigen of Leishmania donovani clinical isolates and its association with antimony resistance.
Tandon R; Chandra S; Baharia RK; Das S; Misra P; Kumar A; Siddiqi MI; Sundar S; Dube A
Antimicrob Agents Chemother; 2014 Jun; 58(6):2997-3007. PubMed ID: 24614385
[TBL] [Abstract][Full Text] [Related]
18. Transcriptome profiling identifies genes/pathways associated with experimental resistance to paromomycin in Leishmania donovani.
Verma A; Bhandari V; Deep DK; Sundar S; Dujardin JC; Singh R; Salotra P
Int J Parasitol Drugs Drug Resist; 2017 Dec; 7(3):370-377. PubMed ID: 29035735
[TBL] [Abstract][Full Text] [Related]
19. Novel mechanism of drug resistance in kala azar field isolates.
Singh N; Singh RT; Sundar S
J Infect Dis; 2003 Aug; 188(4):600-7. PubMed ID: 12898450
[TBL] [Abstract][Full Text] [Related]
20. Visceral leishmaniasis, or kala azar (KA): high incidence of refractoriness to antimony is contributed by anthroponotic transmission via post-KA dermal leishmaniasis.
Singh R; Kumar D; Ramesh V; Negi NS; Singh S; Salotra P
J Infect Dis; 2006 Aug; 194(3):302-6. PubMed ID: 16826477
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]